NCT01707550已完成不适用
Observational, Non-interventional Survey of Renal Allograft Recipients Receiving CellCept as Part of Their Immunosuppressive Protocol
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 414
- 主要终点
- Average dose of CellCept used in immunosuppressive protocols in Serbia
研究概览
简要总结
This observational survey study will capture all renal transplant patients in Serbia who are currently receiving CellCept (mycophenolate mofetil) as part of their immunosuppressive protocol.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult patients, >/= 18 years of age
- •Recipients of renal allograft
- •Patients receiving CellCept
排除标准
- 未提供
结局指标
主要结局
Average dose of CellCept used in immunosuppressive protocols in Serbia
时间窗: 9 months
Average dose of concomitant immunosuppressive drugs
时间窗: 9 months
次要结局
- Average duration of post-transplant period for patients in Serbia receiving CellCept(9 months)
研究者
相似试验
已完成
不适用
Associating Renal Transplantation With the ITN Signature of ToleranceKidney TransplantationNCT01516177National Institute of Allergy and Infectious Diseases (NIAID)250
已完成
不适用
Non-interventional-study With Tacrolimus Sandoz© Capsules for Prophylaxis of Renal Graft RejectionChronic Kidney InsufficiencyNCT01353417Sandoz102
Unknown
不适用
TransplantLines: the Transplantation BiobankSolid Organ Tranplant Recipients, 18+ YearsNCT03272841University Medical Center Groningen3,000
撤回
不适用
Observational Registry Study of Renal Transplant PatientsKidney TransplantNCT01284257Novartis Pharmaceuticals
进行中（未招募）
不适用
Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure RegistryKidney Transplant RejectionNCT03326076CareDx4,000